In this study, Aifang Ma presents China’s national biotechnology strategies and programs and provides an overview of the country’s progress in the medical, industrial, energy and agricultural sectors. As a new challenger on the international stage, China is stepping up its efforts to compete with the United States, the leader in the field. Having become an inescapable power, China will however have to decide between two options: to continue prioritising technological advances by downgrading the regulation of biotechnologies to a secondary position, or to give itself time to reflect on how to cultivate an alternative model of scientific and technological development in order to curb possible ethical abuses.
This study was written by Aifang Ma, Doctoral student and lecturer at the Centre for European Studies and Comparative Politics at Sciences Po, with a degree in French Language and Literature. Having simultaneously completed two Masters Degrees at Beijing Foreign Studies University and Sciences Po Paris in European Affairs, she worked successively at UNESCO in Paris and at the French Embassy in China in Beijing. She is the author of L’intelligence artificielle en Chine : un état des lieux, Fondation pour l’innovation politique, November 2018.